These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 2130925)
1. Fibrinogen Geneva, a new case of A alpha 16 Arg----Cys dysfibrinogenaemia. Furlan M; Bögli C; Hofer A; Bouvier CA; de Moerloose P Blood Coagul Fibrinolysis; 1990 Jun; 1(2):139-43. PubMed ID: 2130925 [TBL] [Abstract][Full Text] [Related]
2. Fibrinogen Bergamo I (A alpha 16Arg----Cys): susceptibility towards thrombin following aminoethylation, methylation or carboxamidomethylation of cysteine residues. Reber P; Furlan M; Beck EA; Finazzi G; Buelli M; Barbui T Thromb Haemost; 1985 Aug; 54(2):390-3. PubMed ID: 4082078 [TBL] [Abstract][Full Text] [Related]
3. [Fibrinogen Bern III: a further case of hereditary fibrinogen variants with substitution A alpha 16 Arg----Cys]. Furlan M; Leupin L; Biasiutti FD; Lämmle B Schweiz Med Wochenschr; 1991 Jul; 121(29):1068-71. PubMed ID: 1891701 [TBL] [Abstract][Full Text] [Related]
4. Fibrinogen Kiel: a congenital dysfibrinogenaemia with (A alpha-16 Arg----His) substitution characterized by HPLC without prior isolation of fibrinogen. Seydewitz HH; Gram J; Bruhn HD; Witt I Blood Coagul Fibrinolysis; 1991 Aug; 2(4):501-6. PubMed ID: 1768762 [TBL] [Abstract][Full Text] [Related]
5. Fibrinogen Milano II: a congenital dysfibrinogenaemia associated with juvenile arterial and venous thrombosis. Haverkate F; Koopman J; Kluft C; D'Angelo A; Cattaneo M; Mannucci PM Thromb Haemost; 1986 Feb; 55(1):131-5. PubMed ID: 3705000 [TBL] [Abstract][Full Text] [Related]
6. Fibrinogen Milano V: a congenital dysfibrinogenaemia with a gamma 275 Arg-->Cys substitution. Steinmann C; Bögli C; Jungo M; Lämmle B; Heinemann G; Wermuth B; Redaelli R; Baudo F; Furlan M Blood Coagul Fibrinolysis; 1994 Aug; 5(4):463-71. PubMed ID: 7841300 [TBL] [Abstract][Full Text] [Related]
7. Fibrinogen Milano IV, another case of congenital dysfibrinogenemia with an abnormal fibrinopeptide A release (A alpha 16 Arg----His). Bögli C; Hofer A; Baudo F; Redaelli R; Furlan M Haemostasis; 1992; 22(1):7-11. PubMed ID: 1521828 [TBL] [Abstract][Full Text] [Related]
8. Fibrinogen kaiserslautern III: a new case of congenital dysfibrinogenemia with aalpha 16 arg-->cys substitution. Loreth RM; Meyer M; Albert FW Haemostasis; 2001; 31(1):12-7. PubMed ID: 11408744 [TBL] [Abstract][Full Text] [Related]
9. Aberrant hepatic processing causes removal of activation peptide and primary polymerisation site from fibrinogen Canterbury (A alpha 20 Val --> Asp). Brennan SO; Hammonds B; George PM J Clin Invest; 1995 Dec; 96(6):2854-8. PubMed ID: 8675656 [TBL] [Abstract][Full Text] [Related]
10. Fibrinogen Matsumoto V: a variant with Aalpha19 Arg-->Gly (AGG-->GGG). Comparison between fibrin polymerization stimulated by thrombin or reptilase and fibrin monomer polymerization. Tanaka H; Terasawa F; Ito T; Tokunaga S; Ishida F; Kitano K; Kiyosawa K; Okumura N Thromb Haemost; 2001 Jan; 85(1):108-13. PubMed ID: 11204560 [TBL] [Abstract][Full Text] [Related]
11. Fibrinogens Bern IV, Bern V and Milano XI: three dysfunctional variants with amino acid substitutions in the thrombin cleavage site of the Aalpha-chain. Stucki B; Zenhäusern R; Biedermann B; Baudo F; Redaelli R; Lämmle B; Furlan M Blood Coagul Fibrinolysis; 1999 Mar; 10(2):93-9. PubMed ID: 10192658 [TBL] [Abstract][Full Text] [Related]
12. Fibrinogen Kanazawa: a congenital dysfibrinogenaemia with delayed polymerization having a replacement of proline-18 by leucine in the A alpha-chain. Uotani C; Miyata T; Kumabashiri I; Asakura H; Saito M; Matsuda T; Kajiyama S; Iwanaga S Blood Coagul Fibrinolysis; 1991 Jun; 2(3):413-7. PubMed ID: 1932527 [TBL] [Abstract][Full Text] [Related]
13. Fibrinogen Barcelona II: a new case of A alpha 16 Arg----His substitution. Borrell M; Vila L; Solá J; Coll I; Fontcuberta J Haemostasis; 1990; 20(1):1-7. PubMed ID: 2323678 [TBL] [Abstract][Full Text] [Related]
14. Fibrinogen St. Gallen I (gamma 292 Gly--> Val): evidence for structural alterations causing defective polymerization and fibrinogenolysis. Stucki B; Schmutz P; Schmid L; Haeberli A; Lämmle B; Furlan M Thromb Haemost; 1999 Feb; 81(2):268-74. PubMed ID: 10064005 [TBL] [Abstract][Full Text] [Related]
15. [Fibrinogen Bern II: hereditary fibrinogen variant with amino acid substitution of arginine replaced by histidine in position 16 of the A alpha chain]. Rupp C; Sievi R; Furlan M; Beck EA Schweiz Med Wochenschr; 1983 Oct; 113(40):1460-2. PubMed ID: 6648427 [TBL] [Abstract][Full Text] [Related]
16. Heterozygous abnormal fibrinogen Osaka III with the replacement of gamma arginine-275 by histidine has an apparently higher molecular weight gamma-chain variant. Yoshida N; Imaoka S; Hirata H; Matsuda M; Asakura S Thromb Haemost; 1992 Nov; 68(5):534-8. PubMed ID: 1455400 [TBL] [Abstract][Full Text] [Related]
17. Three abnormal fibrinogen variants with the same amino acid substitution (gamma 275 Arg----His): fibrinogens Bergamo II, Essen and Perugia. Reber P; Furlan M; Henschen A; Kaudewitz H; Barbui T; Hilgard P; Nenci GG; Berrettini M; Beck EA Thromb Haemost; 1986 Dec; 56(3):401-6. PubMed ID: 3563970 [TBL] [Abstract][Full Text] [Related]
18. A new congenital abnormal fibrinogen Ise characterized by the replacement of B beta glycine-15 by cysteine. Yoshida N; Wada H; Morita K; Hirata H; Matsuda M; Yamazumi K; Asakura S; Shirakawa S Blood; 1991 May; 77(9):1958-63. PubMed ID: 2018836 [TBL] [Abstract][Full Text] [Related]
19. Hereditary dysfibrinogenaemia (fibrinogen Jena)--report of a family study. Maak B Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(4):519-22. PubMed ID: 2465965 [TBL] [Abstract][Full Text] [Related]
20. Analysis of human fibrinopeptides by high-performance liquid chromatography. Kehl M; Lottspeich F; Henschen A Hoppe Seylers Z Physiol Chem; 1981 Dec; 362(12):1661-4. PubMed ID: 7319478 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]